Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Centessa Pharmaceuticals Q2 EPS $(0.38) Misses $(0.34) Estimate

Author: Benzinga Newsdesk | August 12, 2025 06:16am
Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.34) by 11.44 percent. This is a 5 percent increase over losses of $(0.40) per share from the same period last year.

Posted In: CNTA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist